Climbazole
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Climbazole
Climbazole: Known uses and market status in India
Summary
The TxGNN deep-learning model has no candidate with a score of 0.99 or higher for Climbazole, so there is currently no new predicted indication. The drug’s recorded uses are listed below. They are the drug’s own recorded uses, not model candidates.
Quick overview
| Item | Content |
|---|---|
| New predicted indications | None (no model candidate scored 0.99 or higher) |
| Known uses recorded for this drug | 2 |
| Evidence level | Not applicable |
| India Market Status | Listed in a compiled Indian medicine price dataset (3 of 3) – CDSCO approval status is not included in this data |
| Number of Listed Products | 3 (valid: 3) |
Known uses recorded for this drug
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| none | none |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| seborrheic dermatitis |
| seborrheic keratosis |
India Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 134358 | Medkin AD Shampoo | bottle of 200 ml Shampoo | Valid |
| 34828 | Ciola Shampoo | bottle of 100 ml Shampoo | Valid |
| 108105 | Itrakil Shampoo Anti Dandruff | bottle of 100 ml Shampoo | Valid |
Safety Considerations
Please refer to the package insert for safety information.
Points from the prediction review to keep in mind:
- No drug interaction records were found.
- Azoles may cause barrier disruption or sensitization on inflamed skin, relevant if atopic dermatitis is pursued.
- Safety in neonates has not been established, which matters for the neonatal predictions.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.